Adient (ADNT)
(Delayed Data from NYSE)
$22.33 USD
+0.17 (0.77%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $22.33 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
A Value C Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$22.33 USD
+0.17 (0.77%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $22.33 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
A Value C Growth D Momentum B VGM
Zacks News
Adient (ADNT) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of -35.42% and -0.27%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Adient (ADNT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Adient (ADNT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Implied Volatility Surging for Adient (ADNT) Stock Options
by Zacks Equity Research
Adient (ADNT) needs investors to pay close attention to the stock based on moves in the options market lately.
Adient (ADNT) Surges: Stock Moves 7.8% Higher
by Zacks Equity Research
Adient (ADNT) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
New Strong Sell Stocks for December 14th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Should You Get Rid of Adient (ADNT) Now?
by Zacks Equity Research
Adient (ADNT) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
Adient's (ADNT) Q4 Earnings Beat Estimates, Revenues Up
by Zacks Equity Research
The acquisition of Futuris and increase in volume aid Adient's (ADNT) revenue growth.
Adient (ADNT) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of 3.17% and 0.52%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Adient (ADNT) Q4 Earnings Expected to Decline
by Zacks Equity Research
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for October 17th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for October 10th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Adient (ADNT) Benefits From Stabilization of SS&M Segment
by Zacks Equity Research
Adient's (ADNT) SS&M segment gains from its stabilization moves, which are likely to continue in the future.
Adient's (ADNT) Q3 Earnings Miss Estimates, Revenues Up
by Zacks Equity Research
For fiscal 2018, Adient (ADNT) anticipates revenues of around $17.5 billion, up from the prior guidance of $17-$17.2 billion.
New Strong Sell Stocks for July 16th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Company News For Jun 12, 2018
by Zacks Equity Research
Companies In The News are: EVHC,BSX,SYK,SRE,ADNT
New Strong Sell Stocks for May 14th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for May 10th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Delphi (DLPH) to Report Q3 Earnings: A Surprise in Store? (revised)
by Zacks Equity Research
Delphi's (DLPH) frequent acquisitions and alliances might leave a positive impact on its earnings in Q3. However, a weak quarterly guidance is a concern.
Should You Buy Adient (ADNT) Ahead of Earnings?
by Zacks Equity Research
Adient (ADNT) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
What's in Store for Ferrari (RACE) This Earnings Season?
by Zacks Equity Research
Ferrari (RACE) has diverse source of revenues. However, the company has been facing recall problems, which might negatively impact its third-quarter earnings.
Delphi (DLPH) to Report Q3 Earnings: A Surprise in Store?
by Zacks Equity Research
Delphi's (DLPH) frequent acquisitions and alliances might leave a positive impact on its earnings in Q3. However, a weak quarterly guidance is a concern.
Honda (HMC) Q2 Earnings: What???s in Store for the Stock?
by Zacks Equity Research
Honda's (HMC) weak fiscal estimates and a $605-million legal settlement over flawed air-bags might hamper its Q2 results. However, its efforts to launch electric cars might drive the finances.
New Strong Buy Stocks for October 27th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
5 Low Price-to-Book Stocks that Make Solid Bets
by Zacks Equity Research
When it comes to valuation metrics, though P/E and P/S are the first choices, the P/B ratio is also emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.
New Strong Buy Stocks for October 25th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday